Elderberry (Sambucus nigra, Black Elder)
Elderberry (Sambucus nigra, or black elder) is a small European tree whose dark-purple ripe berries are widely used in traditional cold-and-flu remedies — Sambucol syrup is the most-recognised UK brand, with own-brand and own-label products in most pharmacies and supermarkets. Camden uses elderberry as an adjunct in NB-1284 (our Vitamin Gummy with Elderberry), where the authorised UK health claims attach to the vitamin C, zinc, and selenium content — not to the elderberry itself. Three practical things to know: 1. <strong>Modest cold-and-flu symptom signal in trials.</strong> The Hawkins 2018 meta-analysis (PMID 30670267, 4 RCTs n=180) reported that black elderberry "substantially reduced upper respiratory symptoms" with a large mean effect size — but the total trial population is small and the trials are heterogeneous, so the certainty is low. The small Zakay-Rones syrup trials in seasonal influenza are the foundational studies. UK NHS and NICE CKS Common Cold guidance uses symptomatic management (rest, hydration, paracetamol / ibuprofen) and does NOT include elderberry. 2. <strong>NEVER eat raw elderberries, leaves, stems, bark, or roots.</strong> They contain cyanogenic glycosides (sambunigrin) that produce cyanide on digestion. CDC reported a 1984 California outbreak of acute GI illness from raw elderberry juice. Commercial cooked / extracted preparations are safe; foraging and home-preparation without proper cooking is not. 3. <strong>The 2020 "cytokine storm" concern was overstated.</strong> During the early COVID-19 pandemic, some clinicians worried elderberry might worsen severe disease by triggering cytokine release. The mechanism evidence does not support a clinically significant proinflammatory effect at standard supplement doses; mainstream guidance (NIH ODS, UK BDA) does not contraindicate. People on immunosuppressants should still disclose use. UK marketing of elderberry-only preparations cannot carry a UK Article 13.1 health claim — EFSA evaluation of botanical immune claims is on hold. Combined products like NB-1284 carry vitamin/ mineral authorised claims (vitamin C, zinc, selenium contribute to normal immune function). Camden's elderberry-as-adjunct approach is the UK-compliant route.
Camden Medicals editorial · Last reviewed 12 June 2026 · Next review December 2026
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Botanical
- Typical daily dose
- Trial-evidenced acute-cold dosing: standardised elderberry syrup (Sambucol®-type) at 15 mL × 4 daily for 5 days (Zakay-Rones 2004); standardised capsules at 600-2000 mg elderberry extract daily in divided doses. Anthocyanin content in the trial-grade material is typically 200-400 mg anthocyanins per 100 g fresh berry equivalent.
- Top use evidence
- Strong
On this page
What it is
Elderberry (Sambucus nigra L.), also known as black elder or European elder, is a small deciduous tree or shrub in the Adoxaceae family (formerly Caprifoliaceae), native to Europe and parts of western Asia. The flat-topped clusters of small white flowers (elderflowers) and the dark-purple ripe berries are both used in traditional culinary and medicinal preparations.
The medicinal interest is in the ripe berries — properly cooked or extracted, they are a rich source of:
- Anthocyanins — cyanidin-3-glucoside and cyanidin-3-sambubioside are the principal forms (typically 200-400 mg total anthocyanins per 100 g fresh ripe berry). The anthocyanin profile gives commercial preparations their dark-red / purple colour and is the principal standardisation marker for trial-grade material.
- Flavonoids — rutin, quercetin, kaempferol, isorhamnetin glycosides.
- Polyphenols — chlorogenic acid, neochlorogenic acid, and other phenolic acids.
- Vitamin C — modest natural content (~10-30 mg / 100 g fresh berry).
- Sugars — fructose and glucose, plus organic acids (citric, malic).
UK elderberry preparations span:
- Standardised cooked-fruit syrups (Sambucol®, Sambucol Black Elderberry, Pukka Elderberry Syrup, A. Vogel Echinaforce Cold & Flu) — the most-trialled trial-comparable form.
- Standardised dried-fruit capsules at 200-1000 mg/serving with anthocyanin content declared.
- Combined immune products with vitamin C, zinc, vitamin D3 — NB-1284 belongs to this category.
- Lozenges and effervescent tablets for acute cold-symptom use.
- Tea blends — typically dried flower (elderflower) plus fruit.
The cyanogenic-glycoside safety profile is critical: raw elderberries, leaves, stems, bark, and roots contain sambunigrin and related cyanogenic glycosides that release hydrogen cyanide on hydrolysis. Properly cooked berries (boiled at ≥85°C for several minutes) and properly extracted commercial preparations are safe — the cyanogenic glycosides are denatured. Raw or improperly cooked elderberries have produced acute GI illness outbreaks; the most-cited is a 1984 outbreak in Monterey County, California, where adults at a community gathering drank raw juice and developed acute GI illness with elevated cyanide markers. UK consumers using commercial elderberry preparations are not at this risk; foragers and home preparers must cook the berries thoroughly.
Note on elderberry-vs-elderflower: the white flowers (elderflower) are also used in herbal medicine — they are NOT cyanogenic and are widely consumed in cordials and teas. THR-registered elderflower preparations exist for traditional cold / catarrh use. This entry focuses primarily on elderberry (the ripe fruit), which is the active in NB-1284.
At a glance
- Active in NB-1284 (Camden Vitamin Gummy with Elderberry). Authorised UK immune claim attaches to vitamin C / zinc / selenium, NOT to elderberry itself.
- AVOID raw berries / leaves / stems / bark — cyanogenic glycosides (sambunigrin) produce cyanide on digestion. CDC 1984 California outbreak from raw juice. Commercial cooked / extracted preparations are safe.
- Best meta-analytic evidence: Hawkins 2018 PMID 30670267 (4 RCTs n=180) reported a large effect size for upper-respiratory symptom reduction, but the total population is small and heterogeneous (low certainty). The foundational work is the small Zakay-Rones Sambucol® syrup trials in seasonal influenza. UK NHS / NICE CKS Common Cold guidance does NOT include elderberry.
- Active constituents: anthocyanins (cyanidin-3-glucoside, cyanidin-3-sambubioside) + broader flavonoid / polyphenol profile. In vitro antiviral activity against influenza A, influenza B, several rhinoviruses; clinical translation modest.
- EFSA Article 13 evaluation of elderberry immune claims is on hold; UK marketing of elderberry-only preparations cannot make UK health claims. Combined products can carry vitamin / mineral authorised claims.
- The 2020 "cytokine-storm + COVID-19" concern was overstated and is not supported by mechanism evidence at standard supplement doses. Mainstream UK guidance (BDA, NIH ODS) does not contraindicate. Immunosuppressant users should disclose use.
- Pregnancy / breastfeeding: avoid concentrated supplement extracts. Cooked-elderberry food consumption has historical use without identified harm; supplement-tier pregnancy safety not formally established.
What people use it for
Adults wanting an adjunct at the first sign of a cold or flu-like illness
UK guidance leads: the NHS and NICE Clinical Knowledge Summaries manage the common cold and seasonal flu with rest, fluids and simple pain relief (paracetamol or ibuprofen), and do not include elderberry. Many people nonetheless take a standardised elderberry syrup (Sambucol® and similar) at the first sign of symptoms. Beneath the guidance, the research Camden reviewed: the Hawkins 2018 meta-analysis (4 RCTs, n=180) suggests elderberry may reduce upper-respiratory symptoms, but the trials are few, small and heterogeneous, so this is low-certainty. Where elderberry is combined with vitamin C and zinc, the authorised UK immune claim comes from those nutrients, not from the elderberry. [1,2]
Some evidenceLimitedAdults considering elderberry for daily / preventive use through winter
Elderberry is widely taken daily over winter to try to prevent colds and flu; the current evidence does not support this use. Trial evidence is concentrated on short courses started at first symptom onset, not on long-term prevention. The UK NHS-recommended prevention for seasonal flu is the annual influenza vaccination for eligible groups. [2]
Popular, not provenInsufficientAdults on immunosuppressant medication or with autoimmune disease
Elderberry is sometimes taken for immune support by people on immunosuppressant medicines or with autoimmune conditions; the evidence does not support adding it, and the conservative position is to talk to the team managing the condition first. Anthocyanins have shown immune-signalling activity in laboratory studies, so disclosure to the clinical team before adding any immune-active supplement (including NB-1284, which contains elderberry) is the prudent course.
Not supportedInsufficientAdults considering raw or wild-foraged elderberries
Raw elderberries, leaves, stems, bark and roots contain cyanogenic glycosides (sambunigrin) that release cyanide on digestion and are toxic; the US CDC documented a 1984 Monterey County outbreak of acute illness with elevated cyanide markers in adults who drank raw elderberry juice. Only properly cooked berries (boiled at ≥85°C for several minutes) and properly extracted commercial preparations are safe. Wild foraging also requires correct species identification — Sambucus nigra is safe once cooked, whereas Sambucus ebulus (dwarf elder) is more toxic and is best avoided entirely. [3]
Not supportedStrongPregnant or breastfeeding women, or women trying to conceive
Concentrated elderberry supplement extracts are best avoided in pregnancy and breastfeeding because supplement-tier safety has not been formally established. Cooked elderberry in ordinary foods (jam, syrup, cordial) has a long history of use without an identified harm signal. Talk to your midwife, GP or pharmacist before taking any elderberry supplement in pregnancy. [8]
Not supportedLimited
How it works
Elderberry's traditional immune-supportive and antiviral effect is attributed to multiple mechanisms acting together:
Direct antiviral activity — anthocyanins and flavonoids. In vitro studies (Roschek 2009 [PMID 19682714], Krawitz 2011 [PMID 21352539], others) demonstrate that elderberry extracts inhibit influenza A and influenza B haemagglutinin-mediated cell entry, plus rhinovirus replication. The mechanism appears to involve direct binding of anthocyanins to viral surface glycoproteins, blocking attachment to host-cell sialic-acid receptors. Cell-biology effective concentrations are achievable in oral preparations at standard supplement doses.
Modulation of cytokine release. Cell-biology and animal-model work has reported both pro- and anti-inflammatory cytokine modulation by elderberry — IL-1β, IL-6, TNF-α changes with direction depending on the cell type, dose, and stimulation context. The "cytokine storm" concern that circulated in early 2020 — that elderberry would amplify severe COVID-19 inflammation by stimulating cytokine release — was based on a particular reading of this mixed mechanism literature and was overstated in mainstream coverage. Mainstream guidance (NIH ODS, BDA, BMJ Best Practice on COVID-19 supplements) did not contraindicate elderberry on this basis.
Modest immune-cell modulation. Anthocyanins have antioxidant capacity and modulate redox-sensitive transcription factors (Nrf2, NF-κB) in immune cells in cell-biology assays. The downstream effects on immune cell function are modest at clinically achievable plasma anthocyanin concentrations (anthocyanin oral bioavailability is low — typically <1% of oral dose appears as parent compound in plasma, with much higher concentrations of phenolic-acid metabolites).
Polyphenol antioxidant activity. Standard polyphenol antioxidant mechanism with the same translation question that confronts every dietary polyphenol — modest at best at oral food-supplement doses.
Clinical translation: the Hawkins 2018 meta-analysis (PMID 30670267) pooled four RCTs (180 participants) and reported that elderberry supplementation substantially reduced upper-respiratory symptoms relative to placebo, with a large mean effect size. The total trial population is small, the trials are heterogeneous (mixed cold and influenza populations, varying vaccination status), and several were industry-linked — so the certainty is low and the headline effect size should be read with caution. UK NHS and NICE pathways for cold and influenza do not include elderberry. Trial protocols typically dose at first symptom onset and continue for several days.
Common myths
Myth""Elderberry boosts your immune system.""
RealityUK marketing for elderberry cannot make immune-system claims — EFSA's Article 13 evaluation of botanical immune claims is on hold. The mechanism evidence shows mixed cytokine modulation and direct antiviral effect against influenza and rhinovirus in cell biology; the clinical translation is modest reduction in symptom duration. "Boost" framing is editorially loaded and not consistent with what the literature actually shows.
Myth""Elderberry causes cytokine storms / makes COVID-19 worse.""
RealityThe mechanism evidence does not support a clinically significant proinflammatory effect at standard supplement doses. The early-2020 "cytokine storm" concern was based on a particular reading of mixed mechanism literature and was overstated in mainstream coverage. Mainstream guidance (NIH ODS, BDA) did not contraindicate elderberry on this basis. People on immunosuppressants should disclose use to their clinical team.
Myth""Raw elderberries are a healthy raw food.""
RealityDANGEROUS. Raw elderberries, leaves, stems, bark, and roots contain cyanogenic glycosides (sambunigrin) and have caused documented acute GI illness outbreaks (CDC MMWR 1984 California outbreak). Only properly cooked or commercially extracted elderberry preparations are safe. The "raw food" framing for elderberry is dangerous — cooking is not optional. [3]
Myth""Elderberry is a natural Tamiflu.""
RealityDifferent mechanism, vastly different evidence base. Oseltamivir (Tamiflu) is a UK-licensed neuraminidase inhibitor with prescriber-supervised use in influenza prevention and treatment. Elderberry has modest trial evidence on cold/flu symptom duration in non-clinical populations. The "natural Tamiflu" framing is marketing language, not clinical equivalence.
Myth""Elderberry replaces the flu jab.""
RealityIt does not. UK NHS annual influenza vaccination is the recommended prevention intervention for eligible groups. Elderberry is not a substitute and trial evidence does not support it for influenza prevention. [2]
What people say online
Elderberry discourse on TikTok and Reddit clusters around four narratives: "elderberry prevents the flu" (overstated relative to evidence); "homemade elderberry syrup is best" (raw-prep safety concern); "elderberry causes cytokine storm in COVID" (2020-era overstated framing); and Sambucol vs own-brand. This section surfaces the discourse without naming individuals.
Trending claims
- TikTok #fluseason + r/Supplementshigh visibility
Claim: Elderberry prevents the flu naturally
Reality check: Hawkins 2018 PMID 30670267 meta-analysis (4 RCTs n=180) supports modest upper-respiratory symptom reduction — this is duration / severity reduction, not prevention of infection. UK NHS pathway for flu prevention is annual vaccination, particularly for over-65s, pregnant women, frontline staff, and at-risk groups. UK NICE pathway does not include elderberry for flu prevention. [7]
- TikTok #foraging + r/foragingmedium visibility
Claim: Homemade elderberry syrup is better than commercial
Reality check: UNSAFE without proper cooking. Raw elderberries + leaves + stems + bark + roots contain cyanogenic glycosides (sambunigrin) that produce cyanide on digestion. CDC MMWR 1984 documented a California outbreak of acute GI illness from raw elderberry juice. Homemade syrup requires boiling at ≥85°C for ≥10 minutes; leaves / stems / bark must be excluded entirely. Confirm species (S. nigra safe cooked; S. ebulus dwarf elder more toxic, avoid entirely). Commercial preparations are the safer route.
- TikTok + r/CoronavirusUS (2020-era content)medium visibility
Claim: Elderberry causes a cytokine storm in COVID
Reality check: Overstated 2020-era framing. Some clinicians worried elderberry could worsen severe COVID-19 by triggering cytokine release. Mechanism evidence does NOT support a clinically significant proinflammatory effect at standard supplement doses; mainstream guidance (NIH ODS, UK BDA) does not contraindicate elderberry on this basis. People on immunosuppressants should still disclose use to their clinical team.
- TikTok + r/AskUKlow visibility
Claim: Sambucol or Boots own-brand — which?
Reality check: Both contain standardised Sambucus nigra fruit extract; Sambucol is the trial-evidenced brand (Zakay-Rones 2004 used Sambucol®). Own-brand preparations vary in anthocyanin content; check label for species declaration + anthocyanin / standardisation marker. Both are safe (cooked / extracted preparations); the trial-evidenced choice is Sambucol-type.
Where the conversation lives
- TikTok hashtags: #elderberry, #fluseason, #naturalremedies, #foraging, #sambucol
- Reddit subs: r/Supplements, r/foraging, r/AskUK, r/herbalism
- Forums: UK foraging communities, Sambucol brand sites
Questions people are searching
- Does elderberry really prevent flu?
- Can I make my own elderberry syrup safely?
- Is elderberry safe during pregnancy?
- Elderberry or vitamin C for colds?
- Sambucol vs Boots own-brand?
- Did elderberry cause cytokine storms in COVID?
Who drives the discourse: The discourse is driven by four creator classes: cold-and- flu wellness creators (the prevention-framing — mostly overstated); foraging / home-herbalism creators (the homemade-syrup framing — safety concern worth surfacing); COVID-era cautionary creators (the cytokine-storm framing — not mechanism-supported at standard doses); and brand- comparison creators (Sambucol vs own-brand — generally accurate). Verifera editorial does not name individuals.
Social-media trends change quickly. This section is editorial commentary on what people are searching for — not a recommendation.
Common online questions
Synthesised from the questions UK shoppers most often ask online about Elderberry (Sambucus nigra, Black Elder). Each answer is editorial and links to its evidence in the Sources list below.
When should I start elderberry — before I'm sick or only when I notice symptoms?
Trial protocols dose at first symptom onset and continue 5-10 days. The trial-evidenced use is acute / treatment, not chronic prophylactic. UK NHS recommended prevention for seasonal flu is annual influenza vaccination. [2]
Is elderberry syrup safe for kids?
Commercial pediatric elderberry syrups (Sambucol Kids, similar) at on-label paediatric doses are widely used and generally well-tolerated for older children. UK regulatory tier varies — read the label. UK NHS pathway for childhood cold and flu is rest, fluids, paracetamol / ibuprofen at age-appropriate doses; elderberry is a traditional adjunct, not a primary intervention. NEVER give raw elderberry preparations to children — properly cooked or commercially extracted only. [1]
Can I take elderberry with my flu jab?
No specific contraindication. Elderberry is not a substitute for the flu jab; both can be used in the same season (the vaccine for prevention, elderberry for symptom adjunct if a cold or flu does develop). [2]
I'm on chemotherapy — can I take elderberry?
Talk to the oncology team first. Most chemotherapy regimens are accompanied by careful supplement guidance because of possible interaction with the chemotherapy drug or with the immune-suppressed state. Elderberry has no major chemotherapy- interaction signal in the literature, but the conservative position is team disclosure and agreement before adding any supplement.
I picked elderberries from a hedge — can I make my own syrup?
Cook the berries thoroughly (boil at ≥85°C for at least 10 minutes) before consuming. Do NOT use the leaves, stems, bark, or roots — they remain toxic. Confirm species identification — Sambucus nigra (cooked) is safe; Sambucus ebulus (dwarf elder, also called danewort) is more toxic and should be avoided entirely. If unsure, use commercial standardised preparations rather than home-foraged. [3]
UK regulatory landscape
UK regulatory tier: Food supplement
Elderberry sits primarily as food supplement under UK Food Supplements (England) Regulations 2003. Some higher-strength preparations are MHRA THR-registered. There is NO UK-authorised Article 13.1 health claim for elderberry per se; EFSA evaluation of botanical immune claims is on hold. Long history of EU food + supplement + culinary use predates 15 May 1997 — NOT a novel food. Combined products (elderberry + vitamin C / zinc / selenium) can carry the vitamin / mineral authorised UK Article 13.1 immune claims from the vitamin / mineral content — this is the UK-compliant claim route used in NB-1284.
What crosses the tier
| Condition | Crosses to |
|---|---|
| Marketing as cold / flu / COVID prevention or treatment for elderberry alone | |
| Selling raw / unprocessed elderberry preparations for consumption | |
| Sale of S. ebulus (dwarf elder) preparations as if S. nigra | |
| Marketing without raw-preparation safety disclosure for foraging contexts |
Permitted claims
NO standalone UK Article 13.1 authorised health claim for elderberry. Combined elderberry + vitamin C / zinc / selenium products can carry the vitamin / mineral authorised UK Article 13.1 immune claims from the vitamin / mineral content (Camden NB-1284 uses this route). UK MHRA THR-registered elderberry products carry traditional-use indication wording for cold / flu symptomatic relief.
Cross-jurisdiction note
Elderberry is widely used across the EU, UK, North America, and Asia. UK MHRA THR framework + EMA HMPC monograph apply across the EU. US FDA classifies as dietary supplement under DSHEA. Health Canada has a Natural Health Product registration framework with specific Sambucus nigra monographs.
UK regulatory rules evolve. This summary is editorial — businesses should consult regulatory counsel; consumers should consult their pharmacist or GP.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Upper-respiratory-infection symptom duration (cold and influenza-like illness)
LimitedEvidencelimitedUK guidance leads: the NHS and NICE Clinical Knowledge Summaries manage the common cold and seasonal flu with rest, fluids and simple analgesia, and do not list elderberry. Beneath that, the research Camden reviewed: the Hawkins 2018 meta-analysis (PMID 30670267, Complementary Therapies in Medicine) pooled four RCTs (180 participants) of standardised elderberry preparations versus placebo and reported that elderberry substantially reduced upper-respiratory symptoms with a large mean effect size. The total trial population is small, the trials are heterogeneous (mixed cold and influenza populations and vaccination status), and several were industry-linked — so certainty is low and the headline effect size should be read with caution. The small Zakay-Rones Sambucol® syrup trials in seasonal influenza are the foundational materials. [1,2]
Influenza prevention
InsufficientEvidenceinsufficientUK guidance leads: the NHS recommends the annual influenza vaccination for eligible groups as the prevention intervention for seasonal flu. Beneath that, the research Camden reviewed: trial evidence does not support elderberry as a flu-prevention strategy — the trials test short treatment courses at symptom onset, not prevention. [2]
COVID-19 — prevention or treatment
InsufficientEvidenceinsufficientUK guidance leads: the NHS COVID-19 pathway is vaccination plus, for eligible high-risk groups, antiviral medication; no UK or international body recommends elderberry for COVID-19. Beneath that, the research Camden reviewed: there is no supportive trial evidence for elderberry in COVID-19 prevention or treatment. The early-2020 "cytokine storm" concern was based on a particular reading of mixed mechanism literature and was overstated; equally, mainstream guidance did not contraindicate elderberry. "Cleansing" framing applied to elderberry is non-regulated marketing language.
Cardiovascular and metabolic outcomes
InsufficientEvidenceinsufficientUK guidance leads: NICE cardiovascular pathways do not include elderberry. Beneath that, the research Camden reviewed: anthocyanin polyphenols have a broader cardiovascular literature (flavonoid intake is inversely associated with cardiovascular events in observational cohorts), but trial evidence specific to elderberry anthocyanins on cardiovascular endpoints is small and does not support a cardiovascular use. [9]
Effect matrix — per-condition evidence
Per-outcome summary of the published trial corpus: dose ranges studied, duration, evidence grade, and direction of effect. Each row is a citable claim.
| Outcome | Population | Dose | Duration | Evidence | Direction | Sources |
|---|---|---|---|---|---|---|
| Upper respiratory symptom duration | adults | — | 1–2 wk | LimitedEvidencelimited | improvement | PMID 30670267 |
| Hawkins 2018 systematic review + meta-analysis (PMID 30670267) — 4 RCTs n=180. Large mean effect size for upper-respiratory-symptom reduction. LIMITED grade reflects small total trial population (n=180) and trial- quality variability. Moderator analysis examined vaccination status and cause of upper respiratory symptoms. UK NHS: viral URTI is self-limiting and pathway is symptom management, not antibiotic. | ||||||
| Influenza symptom duration | adults | — | 1–2 wk | InsufficientEvidenceinsufficient | improvement | PMID 30670267 |
| Body-text anchors the influenza signal on the small Zakay-Rones Sambucol® syrup trial in seasonal influenza (about 60 participants), included within the Hawkins 2018 meta-analysis (PMID 30670267). INSUFFICIENT grade — a single small foundational trial, not replicated at scale. UK NHS pathway: oseltamivir for at-risk influenza patients; flu vaccination is primary prevention. | ||||||
| In vitro antiviral activity | — | — | StrongEvidencestrong | not assessed | PMID 19682714 PMID 21352539 | |
| In vitro antiviral activity vs influenza A/B and rhinoviruses is well- documented (per body-text evidence_quality summary). Clinical translation to community cold/flu prevention or treatment remains LIMITED at best. STRONG grade applies only to the laboratory finding, not to any consumer outcome — the row exists to keep mechanistic context distinct from clinical claims. | ||||||
Evidence grades follow the editorial convention: strong > moderate > limited > very_limited > insufficient. Direction reports the trial corpus consensus (improvement / no_change / mixed / decrement). Schema cross-emitted at MedicalSubstance.relevantClinicalCondition[].
Clinical literature review
The elderberry literature is anchored on the small Zakay-Rones Sambucol® syrup trials in seasonal influenza (the 2004 trial enrolled about 60 participants) and a small handful of subsequent RCTs synthesised in Hawkins 2018 Complementary Therapies in Medicine PMID 30670267 (meta-analysis of 4 RCTs n=180; large mean effect size for upper-respiratory-symptom reduction, but low certainty given the small, heterogeneous, partly industry-linked trials). The cyanogenic-glycoside acute-toxicity safety record from raw consumption is well-characterised (CDC MMWR 1984 California outbreak). UK NICE CKS Common Cold + Influenza do NOT include elderberry; UK NHS pathway is symptomatic management.
Key trials
Hawkins J, Baker C, Cherry L, Dunne E · 2018 · Complement Ther Med · PMID 30670267
Finding: Black elderberry (Sambucus nigra) supplementation was found to substantially reduce upper respiratory symptoms across 4 RCTs n=180 participants. Quantitative synthesis yielded a large mean effect size. Moderator analysis evaluated vaccination status and cause of upper respiratory symptoms. Authors present elderberry as an alternative to antibiotic misuse for viral upper- respiratory infections, and a potentially safer alternative to prescription drugs for routine common cold and influenza cases.
Relevance: The most recent and largest meta-analysis of elderberry for cold / influenza. Effect size is large but total trial population (n=180) is modest. Trial-quality concerns + small total n limit clinical translation confidence; UK NICE pathway does not include elderberry.
Systematic reviews
- pmid:30670267
Hawkins 2018 Complement Ther Med — 4 RCTs n=180, black elderberry supplementation substantially reduced upper respiratory symptoms with large mean effect size. Modest total n; high heterogeneity across causes / vaccination status.
Evidence quality summary
Upper-respiratory-symptom duration reduction — LIMITED certainty (Hawkins 2018 PMID 30670267 4 RCTs n=180, large effect size but small total n). In vitro antiviral activity (influenza A/B, rhinoviruses) — HIGH certainty. Clinical translation to community-level cold / flu prevention or treatment — INSUFFICIENT certainty (no UK NICE pathway inclusion). Cyanogenic-glycoside acute toxicity from raw consumption — HIGH certainty (decades of case- report literature including CDC MMWR 1984). The 2020-era cytokine-storm + COVID-19 concern — overstated; mechanism evidence does not support clinically significant pro- inflammatory effect at standard supplement doses.
Known gaps
- Larger UK-context RCTs of standardised elderberry preparations in NHS-population cold-and-flu management.
- Direct head-to-head trials of elderberry vs zinc lozenges or vitamin C in acute cold symptoms.
- Long-term safety + efficacy data on chronic / daily prophylactic use (current trial-evidenced pattern is short acute course).
- Pregnancy + breastfeeding safety data for standardised supplement preparations (currently absent).
This summarises the published evidence as of the last review date — it is not advice for your specific situation. Talk to your pharmacist or GP.
Safety
Properly cooked or commercially extracted elderberry is well- tolerated for most adults at standard supplement doses. The critical safety message is to avoid raw elderberries, leaves, stems, bark, and roots. Other realistic considerations are pregnancy avoidance for concentrated extracts and disclosure to clinical teams managing autoimmune disease or immunosuppression.
Talk to your pharmacist or GP first if you:
- You take an immunosuppressant (transplant, biologic DMARDs, ciclosporin) — disclose use.
- You have diagnosed autoimmune disease — disclose use; conservative practice is team agreement before adding any immune-modulating supplement.
- You take a prescribed diuretic — elderberry has mild diuretic effect at high doses; modest clinical relevance.
- You take an oral diabetes medicine — theoretical mild hypoglycaemic effect; monitor glucose if added.
- You are pregnant or breastfeeding — avoid concentrated supplement extracts.
- You are giving any preparation to a young child — read paediatric dosing on the product; avoid any home-foraged or raw preparation.
Common side effects: Generally well-tolerated. Mild GI upset (nausea, diarrhoea) at high doses. Allergic reactions are rare. RAW preparations are toxic — only properly cooked / extracted forms are safe.
Pregnancy and breastfeeding
Avoid concentrated supplement extracts in pregnancy. Cooked elderberry in food (jam, syrup, cordial) has historical safe use; supplement-tier pregnancy safety is not formally established. Talk to your midwife or GP if you've been taking elderberry supplements and are uncertain about a specific product.
As pregnancy. Avoid concentrated elderberry supplement extracts during breastfeeding. Cooked food-tier elderberry use has historical record without identified harm.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- RAW elderberry preparations (any context).
- Hypersensitivity to elderberry or other Adoxaceae / Caprifoliaceae plants.
- Pregnancy and breastfeeding for concentrated supplement extracts.
- Sambucus ebulus (dwarf elder) — distinct species, more toxic, should be avoided entirely.
Drug interactions
Immunosuppressants (ciclosporin, tacrolimus, biologic DMARDs, mycophenolate) · medium
Effect: Theoretical pharmacodynamic interaction — elderberry anthocyanins have in-vitro immune-modulating activity (cytokine signalling). The 2020-era "cytokine-storm" concern was overstated for healthy populations but for people on prescribed immunosuppression, disclosure is the appropriate caution.
Mechanism: Anthocyanin polyphenols have documented in-vitro immune signalling effects (NF-κB pathway modulation). Mainstream UK guidance (BDA, NIH ODS) does not contraindicate elderberry at standard doses in healthy populations, but prescribed immunosuppression warrants clinical-team disclosure of any immune-active supplement.
Action: Tell the team managing your transplant, autoimmune disease biologic therapy, or other prescribed immunosuppression about elderberry use (including NB-1284 Vitamin Gummy with Elderberry or any combination product containing elderberry).
Source: BNF immunosuppressants + UK NICE pathway-specific guidance
Oral diabetes medicines — theoretical mild hypoglycaemic effect at high elderberry doses; monitor glucose if you start a course of standardised elderberry syrup while on insulin / sulphonylureas.
Diuretics — additive mild diuretic effect (modest clinical significance).
Anti-cancer agents — no major specific signal in the literature; disclose to oncology team for routine supplement-disclosure rule.
Tell your prescriber if you take any of these combinations. This is not personalised advice.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Mild GI upset (nausea, diarrhoea, abdominal cramping) at higher doses.
Rare side effects
- Allergic reactions (rare).
- Headache.
- Acute toxicity from RAW preparations — nausea, vomiting, diarrhoea, weakness, with elevated cyanide markers in severe cases. Properly cooked / extracted preparations are not at risk.
- Theoretical autoimmune-disease activity changes (no published clinical trial evidence).
How to take it
- Typical supplemental range
- Trial-evidenced acute-cold dosing: standardised elderberry syrup (Sambucol®-type) at 15 mL × 4 daily for 5 days (Zakay-Rones 2004); standardised capsules at 600-2000 mg elderberry extract daily in divided doses. Anthocyanin content in the trial-grade material is typically 200-400 mg anthocyanins per 100 g fresh berry equivalent.
- Timing
- Acute use at first cold-symptom onset, continued 5-10 days. Three-to-four-times-daily dosing is the trial-protocol pattern.
How to spot quality
Look for
- Plant species declared as Sambucus nigra (NOT S. ebulus / dwarf elder, which is more toxic).
- Anthocyanin content per serving stated, ideally with the standardisation marker (cyanidin-3-glucoside or total anthocyanins) declared.
- Properly cooked / extracted preparation (raw-berry powders that have not been heat-treated should be avoided).
- GMP-certified manufacture.
- Heavy-metal screen disclosed on spec sheet.
- For combined immune products: vitamin C and / or zinc included to deliver an authorised UK immune claim alongside the elderberry adjunct.
Red flags
- Raw / unheated elderberry powder products marketed for direct consumption — cyanogenic-glycoside concern.
- No species declaration or species declared as Sambucus ebulus / dwarf elder.
- No anthocyanin content stated.
- Marketing as a "natural Tamiflu" or replacement for flu vaccination.
- Marketing as a COVID-19 prevention or treatment.
- Cleansing-marketing framing — non-regulated language.
- Combination products with kava (banned in UK as a food supplement).
Where Camden lands · meets the bar
Camden Medicals retails NB-1284 (Vitamin Gummy with Elderberry) — a combination immune-cluster product where elderberry is one of several actives alongside vitamin C, vitamin D3, zinc, and other authorised-claim minerals. The Verifera editorial position is that elderberry is a worthwhile adjunct in a combination product where the authorised UK Article 13.1 immune claim attaches to the vitamin C / zinc / selenium content; elderberry alone cannot carry a UK health claim while EFSA's Article 13 botanical claim evaluation remains on hold. Camden does not currently retail a single-active elderberry SKU. For acute cold-symptom use, standardised Sambucol-style preparations (with declared anthocyanin content + properly cooked / extracted source) are the appropriate tier. Quality entry conditions for any future Camden elderberry SKU — declared Sambucus species (S. nigra, not S. ebulus / dwarf elder); declared anthocyanin content (typically 15-30 % anthocyanins for trial-grade material); properly cooked / extracted source with cyanogenic-glycoside assurance; UK GMP manufacture; clear short-term-use guidance.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Vitamin C
Limited evidenceThe classic UK immune-cluster pairing — vitamin C provides the UK Article 13.1 authorised immune claim; elderberry provides the traditional cold/flu adjunct framing.
Vitamin C is required for normal immune-cell function (neutrophil chemotaxis, lymphocyte proliferation, oxidative-burst capacity) and carries the UK Article 13.1 authorised claim "Vitamin C contributes to the normal function of the immune system" at intakes above the 12 mg NRV trigger. Elderberry anthocyanins have direct antiviral activity against influenza and rhinovirus in cell-biology assays.
The pairing is regulatory-strategic and mechanism-additive: the vitamin C provides the authorised front-of-pack immune claim that elderberry cannot make, while the elderberry contributes a traditional cold/flu adjunct positioning. The combination appears across UK winter immune supplements and is the active core of NB-1284.
Trial evidence specific to the combination on hard endpoints is small; each component has its own modest trial body. UK NHS first-line for acute cold remains rest, fluids, simple analgesia.
Evidence: Vitamin C UK Article 13.1 immune claim authorised (gb-nhc:vitamin_c). Elderberry systematic review evidence modest. Combination trials small. [6]
Doses studied: Elderberry extract 300-1000 mg + vitamin C 80-1000 mg, daily for 5-10 day acute course.
Zinc
Limited evidenceAcute-cold-symptom cluster pairing — elderberry direct antiviral activity plus zinc anti-rhinoviral activity for cold-symptom duration.
Zinc lozenges (zinc gluconate or zinc acetate at 75-100 mg/day in divided doses across the day, taken within 24 hours of cold-symptom onset) have Cochrane review support (Hemilä) for reducing common-cold duration via direct antiviral effect against rhinovirus 3C-protease. Zinc carries the UK Article 13.1 authorised immune claim. Elderberry provides direct antiviral activity against influenza A, influenza B, and several rhinoviruses via anthocyanin binding to viral surface glycoproteins.
The combination is mechanism-additive on the antiviral axis, with the zinc contributing the UK authorised immune claim. The combination appears widely in UK acute-cold lozenges, syrups, and effervescent tablets, and is part of NB-1284's active mix.
Evidence: Zinc Cochrane evidence supportive for cold duration. Elderberry systematic review evidence supportive. Combined trials limited. [6]
Doses studied: Elderberry extract 300-1000 mg + zinc gluconate / zinc citrate 10-25 mg per dose (high-dose zinc lozenge regimen 75-100 mg/day in divided doses for the cold-duration effect), 5-10 day acute course.
Echinacea (Echinacea purpurea / E. angustifolia / E. pallida)
Limited evidenceAcute-cold THR-sibling pairing — echinacea immune-cell-modulation plus elderberry direct antiviral activity in a single short-course preparation.
Echinacea (alkamides + cichoric acid + polysaccharides) modulates innate immune cell function — macrophage cytokine release, dendritic-cell maturation, NK-cell activity — across multiple axes. Elderberry anthocyanins provide direct antiviral activity against influenza and rhinovirus.
The combination is mechanism-complementary: echinacea on the immune-cell-modulation axis, elderberry on the antiviral axis. The combination appears in many UK acute-cold products (A. Vogel Echinaforce® Cold & Flu, Sambucol Plus, similar) often alongside zinc and vitamin C. Note that Echinacea is in the Asteraceae family and triggers the Asteraceae-allergy contraindication; elderberry does not have this concern. Both share the conservative-disclosure rule for autoimmune disease and immunosuppressant therapy.
Evidence: Mechanism complementary (immune-cell modulation + direct antiviral). Each component has its own mixed trial evidence. Combination trials small.
Doses studied: Elderberry extract 300-1000 mg + Echinacea purpurea standardised extract 200-500 mg, 5-10 day acute course at first cold-symptom onset.
Vitamin D3
Limited evidenceWinter-immune-cluster pairing — vitamin D3 (UK NHS-recommended winter supplement at 10 µg/day) plus elderberry adjunct for cold-symptom support.
Vitamin D is required for normal immune-cell function and carries the UK Article 13.1 authorised claim "Vitamin D contributes to the normal function of the immune system". UK NHS recommends 10 µg/day (400 IU) vitamin D3 supplementation in autumn and winter for all UK adults because of low UV-B exposure at UK latitudes. Elderberry provides the cold/flu-symptom adjunct framing.
The combination is regulatory-strategic and mechanism-supportive — vitamin D for general immune sufficiency through the winter, elderberry for acute cold-symptom adjunct use. The combination appears in many UK winter immune products and is part of NB-1284's active mix.
Evidence: Vitamin D UK Article 13.1 immune claim authorised (gb-nhc:vitamin_d3). Trial evidence for vitamin D supplementation and respiratory infection is mixed (Martineau 2017 IPD meta-analysis modestly positive). Combination with elderberry not directly trialled. [6]
Doses studied: 10-25 µg/day vitamin D3 + elderberry extract 300-1000 mg, daily through autumn / winter for general immune sufficiency framing.
Verifera™ editorial perspective
Why it matters. Elderberry is one of the most-marketed UK cold-and-flu botanicals (Sambucol etc.) and a Camden adjunct active in NB-1284. Consumer marketing frequently overstates the trial-evidence base (Hawkins 2018 meta-analysis is supportive but n=180 across 4 trials is modest) and occasionally underplays the raw-elderberry cyanogenic- glycoside safety message. The Verifera editorial position is to surface both honestly, anchor in the NB-1284 compliant-claim-route (vitamin/mineral claims, not elderberry), and keep the 2020 cytokine-storm framing in proper context.
Where Camden lands. Camden Medicals uses elderberry as an adjunct in NB-1284 Vitamin Gummy with Elderberry (alongside vitamin C, vitamin D3, zinc, selenium). The authorised UK Article 13.1 immune claims on NB-1284 attach to the vitamin / mineral content, not to the elderberry — this is the UK-compliant route. For consumers researching elderberry: standardised cooked / extracted preparations (Sambucol etc.) are safe; raw berry / leaf / stem / bark consumption is toxic; commercial preparation with species declaration (S. nigra not S. ebulus) is the minimum quality bar.
If you want to explore further. For uncomplicated viral upper-respiratory infections the UK NHS pathway is rest, hydration and simple analgesia (paracetamol or ibuprofen) for symptoms; the common cold and flu are self-limiting. Where people choose elderberry, the trial materials were standardised cooked / extracted syrups (the studied range is in the dosage section), with the species declared as Sambucus nigra (not S. ebulus) and anthocyanin content stated on the label. In pregnancy or breastfeeding, concentrated extracts are best avoided, though cooked elderberry in ordinary foods has a long history of use. Talk to your pharmacist or GP before starting any supplement if you take prescribed medicines or have an existing condition.
How this entry was researched
Authoritative sources consulted:
- NHS Common cold + Flu pages
- NICE CKS Common cold + Influenza
- MHRA Traditional Herbal Registrations register
- BHMA Herbal Compendium (Sambucus nigra)
- EMA HMPC Sambucus nigra community monograph
- CDC MMWR 1984 California outbreak of acute illness from raw elderberry juice
- NIH ODS (US) cytokine-storm assessment for elderberry + COVID-19
- GB Nutrition and Health Claims (NHC) Register (no authorised elderberry claim; combined products carry vitamin / mineral claims)
- PubMed (via E-utilities MCP, 2026-05-12)
PubMed search terms:
elderberry Sambucus influenza common cold meta-analysis
Literature search date: 2026-05-12
Sources listed are those consulted by the Verifera™ editorial team. Readers should verify against current authoritative sources.